Molecular scanning of the insulin receptor substrate 1 gene in subjects with severe insulin resistance: Detection and functional analysis of a naturally occurring mutation in a YMXM motif

Diabetes

Volumn 47, Issue 5, 1998, Pages 837-839

  Whitehead, Jonathan P ^a   Humphreys, Phillippa ^a   Krook, Anna ^c   Jackson, Robert ^a   Hayward, Amanda ^a   Lewis, Helen ^b   Siddle, Kenneth ^a   O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; ENZYME PHOSPHORYLATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; INSULIN RESISTANCE; MITOGENICITY; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031918759     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.837     Document Type: Article

References (18)

1. Krook A, O'Rahilly S: Mutant insulin receptors in syndromes of insulin resistance. In Balliere's Clinical Endocrinology and Metabolism. Shepherd M, Franklyn J, Eds. London, Balliere Tindall, 1996, p. 97-122
2. Krook A, Kumar S, Laing I, Boulton AJM, Wass JAH, O'Rahilly S: Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 43:357-368, 1994
3. Moller DE, Cohen O, Yamaguchi Y, Assiz R, Grigorescu F, Eberle A, Morrow LA, Moses AC, Flier JS: Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 43:247-255, 1994
4. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PM, Cahill DA, Goldstein BJ, White MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991
5. White MF: The insulin signalling system and the IRS proteins. Diabetologia 40:S2-S17, 1997
6. Tanti JF, Gremeaux T, Van Obberghen E, Le Marchand Brustel Y: Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269:6051-6057, 1994
7. Mothe I, Van Obberghen E: Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 271:11222-11227, 1996
8. Sun XJ, Crimmin DL, Myers MG, Miralpeix M, White MF: Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol 13:7418-7428, 1993
9. Nishiyama M, Wands JR: Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 183:280-285, 1992
10. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778, 1993
11. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pederson O: Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828-832, 1993
12. Almind K, Inoue G, Pederson O, Kahn CR: A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. J Clin Invest 97:2569-2575, 1996
13. Yoshimura R, Araki E, Ura S, Todaka M, Tsuruzoe K, Furukawa N, Motoshima H, Yoshizato K, Kaneko K, Matsuda K, Kishikawa H, Shichiri M: Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling. Diabetes 46:929-936, 1997
14. Rocchi S, Tartare-Deckert S, Mothe I, Van Obberghen E: Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the Tyrosine phosphatase 2C and phosphatidylinositol 3-kinase. Endocrinology 136:5291-5297, 1995
15. Shoelson SE, Chatterjee S, Chaudhuri M, White MF: YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc Natl Acad Sci 89:2027-2031, 1992
16. Songyang Z, Carraway KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ, Cantley LC: Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-539, 1995
17. Krook A, Moller DE, Dib K, O'Rahilly S: Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. J Biol Chem 271:7134-7140, 1996
18. Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwens M, Baker C, Hayward AC, Sen SK, Maassen JA, Siddle K, Tavare JM, O'Rahilly S: Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects. J Biol Chem 272:30208-30214, 1997